UK markets closed

Stratec SE (0RAR.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
85.20+1.57 (+1.87%)
At close: 06:00PM GMT

Stratec SE

Gewerbestrasse 37
Birkenfeld 75217
49 7082 7916 0

Full-time employees1,449

Key executives

NameTitlePayExercisedYear born
Mr. Marcus WolfingerChairman of Board of Management & CEO972kN/A1967
Dr. Robert SiegleDirector of Fin. & HR and Member of Board of Management775kN/A1967
Dr. Claus VielsackDirector of Product Devel. & Member of Board of Management601kN/A1967
Mr. Hermann LeistnerFounder & AdvisorN/AN/A1946
Dr. George BauerMember of Management BoardN/AN/A1973
Mr. Jan KeppelerHead of Investor Relations, Sustainability & Corp. CommunicationsN/AN/AN/A
Mr. Roland UtzHead of Supply Chain Management & Sr. VPN/AN/AN/A
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.


Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It operates through three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment designs and manufactures automated analyzer systems, including service parts and consumables for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications. The Smart Consumables segment develops and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technologies. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.

Corporate governance

Stratec SE’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.